Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
Respect the role (and confidentiality) of the EAB at UCSD—and at all NCI-designated cancer centers
Guest Editorial

Respect the role (and confidentiality) of the EAB at UCSD—and at all NCI-designated cancer centers

Over the years, I have gained extensive experience with academic cancer center External Advisory Boards, including hosting multiple EAB meetings at my own cancer center, chairing the EABs of nine other NCI designated cancer centers, and serving on many others. 
June 09, 2023
Vol.49 No.23
By George J. Weiner
UCSD Moores EAB:  A leak to The Cancer Letter derailed the iterative process
Letter To The Editor

UCSD Moores EAB: A leak to The Cancer Letter derailed the iterative process

The UCSD Moores Cancer Center External Advisory Board is extremely disappointed in the commentary included in the most recent issue of The Cancer Letter regarding MCC.
June 09, 2023
Vol.49 No.23
By EAB members UCSD Moores Cancer Center
A letter to members of the UCSD Moores Cancer Center

A letter to members of the UCSD Moores Cancer Center

The following email was sent to members of UCSD Moores Cancer Center on Saturday, June 3. The email addresses The Cancer Letter story focused on the resignation of the center’s director Joe Califano and on problems at the institution.
June 09, 2023
Vol.49 No.23
Should journalists report on matters that involve EABs?
Editorial

Should journalists report on matters that involve EABs?

The facts of my story about UCSD Moores Cancer Center in last week’s issue of The Cancer Letter (June 2, 2023) don’t seem to be in dispute.
June 09, 2023
Vol.49 No.23
By Paul Goldberg
UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil

UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil

The Moores Cancer Center at UC San Diego Health is in imminent danger of losing its Comprehensive designation, and members of the center’s External Advisory Board are urging the leadership of the parent institution to act fast. 
June 02, 2023
Vol.49 No.22
By Paul Goldberg
In Brief

Ezra Cohen named chief medical officer of oncology at Tempus

Ezra Cohen was named chief medical officer of oncology at Tempus, an artificial intelligence and precision medicine company. 
June 02, 2023
Vol.49 No.22
In Brief

Jason Sicklick appointed co-leader of the Structural and Functional Genomics Research Program at UCSD Moores Cancer Center

Jason Sicklick was appointed co-leader of the Structural and Functional Genomics Research Program at UC San Diego Moores Cancer Center. 
April 28, 2023
Vol.49 No.17
Joseph Califano named director of UCSD Moores Cancer Center
Conversation with The Cancer Letter

Joseph Califano named director of UCSD Moores Cancer Center

“There’s nothing like a deadline to make sure you get done what you need to get done.” Joseph A. Califano III, a head and neck surgeon scientist, was named director of Moores Cancer Center at UC San Diego Health, an NCI-designated Comprehensive Cancer Center that serves San Diego County.
November 18, 2022
Vol.48 No.42
By Paul Goldberg
Clinical Roundup

UCSD and VA San Diego study shows genetic score predicts risk of prostate cancer

Researchers at University of California San Diego School of Medicine and the VA San Diego Healthcare System, with colleagues elsewhere, report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer. 
November 04, 2022
Vol.48 No.40
In Brief

UCSD receives $16M NIH FIRST Award to recruit 12 diverse, early-career researchers

UC San Diego has received a five-year, $16 million grant from NIH Common Fund’s Faculty Institutional Recruitment for Sustainable Transformation Program will enable the University of California San Diego to recruit 12 diverse, early-career research faculty in the biomedical sciences. This is the largest grant received by UC San Diego to enhance faculty diversity.
September 23, 2022
Vol.48 No.34

Posts navigation

Previous123Next

Trending Stories

  • Trump administration is removing the mainstays of NCI and the federal government’s cancer program
    Peer review, registries, and evidence-based patient information take a big hit
  • NIH eliminates the NCI Board of Scientific Advisors
    Over its 28 year history, BSA shaped NCI-funded extramural science
  • Bhattacharya cancels NIH all-hands meeting
  • Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
    An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies
  • In the Headlines: “There’s no one to stand up for NCI right now.”
  • George Weiner: Cancer centers are special, as are site visits in CCSG review

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account